Propiedad y actividad de insiders de Janux Therapeutics, Inc. (JANX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $16.25 |
| Capitalización | $991M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-31 | Campbell David Alan | G-Gift | 123,840 | |
| 2026-07-08 | Campbell David Alan | M-Exempt | 7,000 | $29K |
| 2026-07-08 | Campbell David Alan | M-Exempt | 7,000 | $29K |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | A-Award | 15,500 | $212K |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | A-Award | 5,500 | |
| 2026-06-11 | Simson Jake | A-Award | 15,500 | $212K |
| 2026-06-11 | Simson Jake | A-Award | 5,500 | |
| 2026-06-11 | Kung Winston | A-Award | 15,500 | $212K |
| 2026-06-11 | Kung Winston | A-Award | 5,500 | |
| 2026-06-11 | Hernday Natasha | A-Award | 15,500 | $212K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $658000 | $7.8M | $35.6M | $51.4M | $19.2M | $430.6M | $52.3M |
| Inversiones a Corto | 0 | 0 | $339.4M | $275.6M | $324.8M | $594.6M | $914.2M |
| Cuentas por Cobrar | 0 | $8.0M | $200000 | $700000 | $2.2M | $5.4M | $6.4M |
| Inventario | 0 | 0 | 0 | -$700000 | 0 | 0 | 0 |
| Activos Corrientes | $658000 | $16.1M | $377.0M | $332.4M | $349.2M | $1.03B | $975.9M |
| Inmovilizado Material | $21000 | $155000 | $1.6M | $29.4M | $27.8M | $24.1M | $22.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $679000 | $16.2M | $379.8M | $364.0M | $380.4M | $1.06B | $1.01B |
| Cuentas por Pagar | $267000 | $428000 | $2.5M | $2.2M | $2.4M | $4.0M | $5.0M |
| Deuda a Corto | $4.0M | 0 | 0 | 0 | 0 | 0 | $2.4M |
| Pasivos Corrientes | $4.6M | $3.2M | $12.8M | $16.5M | $13.0M | $17.5M | $25.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $8.6M | $30.9M | $13.5M | $43.3M | $36.1M | $38.7M | $50.7M |
| Reservas | -$8.0M | -$14.7M | -$47.4M | -$110.5M | -$168.8M | -$237.8M | -$351.4M |
| Patrimonio Neto | -$7.9M | -$14.6M | $366.3M | $320.7M | $344.3M | $1.02B | $956.8M |
| Deuda Total | $4.0M | 0 | $194000 | $25.3M | $24.5M | $23.0M | $22.1M |
| Deuda Neta | $3.3M | -$7.8M | -$374.8M | -$301.7M | -$319.5M | -$1.00B | -$944.4M |
| Capital Circulante | -$4.0M | $12.9M | $364.2M | $315.9M | $336.2M | $1.02B | $950.9M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 16.35 |
Rentabilidad
| Rentabilidad sobre capital | -10.79% |
| Rentabilidad sobre capital invertido | -15.11% |
| Rentabilidad sobre activos | -10.18% |
| Margen bruto | 68.91% |
| Margen operativo | -450.30% |
| Margen neto | -321.81% |
Empresas relacionadas: ABCL · BHVN · CLDX · HRMY · IMNM · MAZE · NUVB
Explorar sector: Healthcare · Biotechnology
Más secciones de JANX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones